Table 1.
Demographic, clinical, and paraclinical profiles of four patients confirmed with MPXV in Venezuela.
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | |
|---|---|---|---|---|
| Demographics | ||||
| Age, years | 26 | 25 | 32 | 20 |
| Clinics | ||||
| No. of sexual partners in the last month | 0 | 2 | 2 | 7 |
| Maximum number of concurrent lesions | 10–50 | 10–50 | 51–100 | 10–50 |
| CD4 count | N/A | N/A | N/A | 577 |
| HIV viral load, copies/mL | Undetectable | 161,000 | Undetectable | Undetectable |
| Smallpox vaccination history | No | No | No | No |
| Lesion morphology | Vesicular | Vesicular | Vesicular | Vesicular |
| Lesion resolution time, days | 10 | 14 | 12 | 13 |
| Complication | None | Proctitis | None | Penile ulcer |
| Outcome | Full recovery | Full recovery | Full recovery | Full recovery |
| Paraclinics | ||||
| White blood cells, × 103/mL | N/A | 7.9 | N/A | 5.5 |
| Neutrophils, × 103/mL | N/A | 5.21 | N/A | 2.86 |
| Lymphocytes, × 103/mL | N/A | 2.21 | N/A | 1.27 |
N/A: not available.